Earnings Snapshot: Six Flags Entertainment Corp (SIX), Allergan, Inc. (AGN) and Petmed Express Inc (PETS)

Six Flags Entertainment Corp (NYSE:SIX), Allergan, Inc. (NYSE:AGN) and Petmed Express Inc (NASDAQ:PETS) came out with their latest quarterly results on 21st July, 2014.

Six Flags Entertainment Corp (NYSE:SIX), the world’s largest regional theme park company, reported second quarter revenues of $376.55 million, up from last year’s second quarter revenues of $363.7 million. Six Flags Entertainment Corp (NYSE:SIX) had a substantial increase in its net income, which came in at $66.3 million, or $0.67  per diluted share, compared to $47.36 million, or $0.47  per share it posted in the second quarter of 2013.

Six Flags Entertainment Corp (NYSE:SIX)

“The nine percent growth in our Active Pass Base, record-high guest satisfaction ratings, and robust guest spending per capita through the first six months of the year all indicate continued strength in our business. We remain solidly on track to deliver our $500 million Modified EBITDA Target by 2015,” Jim Reid-Anderson, Chairman, President and CEO of Six Flags Entertainment Corp (NYSE:SIX) commented on the results of the Company.

Allergan, Inc. (NYSE:AGN) surprised the Street, when along with its second quarter earnings, it announced that it would be laying off 1,500 of its workers as part of its “stockholder value enhancement” initiative. Allergan, Inc. (NYSE:AGN)’s revenues for the quarter grew by 13% to $1.86 billion from $1.60 billion in the same quarter last year. Net earnings of the company stood at $1.37 per diluted share, up from $1.17 per diluted share in the second quarter of 2013.

In its first fiscal quarter results for 2014 statement, Petmed Express Inc (NASDAQ:PETS) declared net sales of $72.5 million compared to $74.2 million for the same period the prior year, which shows a decrease of 2.2%. The net income of the company amounted to $5 million, or $0.25 per diluted share, compared to $4.8 million, or $0.24 per share for the same quarter last year. The company acquired 184,000 new customers in its first fiscal quarter compared to 207,000 for the same period in 2013.

Petmed Express Inc (NASDAQ:PETS)’s CEO and President, Menderes Akdag said: “We were able to increase our gross margins for the second consecutive quarter and decrease our operational expenses to improve our bottom line results for the quarter ended June 30, 2014”.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!